JP2013510169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510169A5 JP2013510169A5 JP2012538031A JP2012538031A JP2013510169A5 JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5 JP 2012538031 A JP2012538031 A JP 2012538031A JP 2012538031 A JP2012538031 A JP 2012538031A JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- amount
- domain
- compound
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 3
- 210000003097 mucus Anatomy 0.000 claims 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 2
- 102000005348 Neuraminidase Human genes 0.000 claims 2
- 108010006232 Neuraminidase Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 101000809450 Homo sapiens Amphiregulin Proteins 0.000 claims 1
- 102000043494 human AREG Human genes 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25903309P | 2009-11-06 | 2009-11-06 | |
| US25905509P | 2009-11-06 | 2009-11-06 | |
| US61/259,055 | 2009-11-06 | ||
| US61/259,033 | 2009-11-06 | ||
| US32281310P | 2010-04-09 | 2010-04-09 | |
| US61/322,813 | 2010-04-09 | ||
| US33206310P | 2010-05-06 | 2010-05-06 | |
| US61/332,063 | 2010-05-06 | ||
| US38142010P | 2010-09-09 | 2010-09-09 | |
| US61/381,420 | 2010-09-09 | ||
| PCT/US2010/055636 WO2011057081A1 (en) | 2009-11-06 | 2010-11-05 | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013510169A JP2013510169A (ja) | 2013-03-21 |
| JP2013510169A5 true JP2013510169A5 (cg-RX-API-DMAC7.html) | 2013-12-26 |
Family
ID=43970356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012538031A Pending JP2013510169A (ja) | 2009-11-06 | 2010-11-05 | 呼吸器管の治療及び予防のための方法、化合物、及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US8398971B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2496251A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013510169A (cg-RX-API-DMAC7.html) |
| CN (1) | CN102711807A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2010315024B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2780193A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL219579B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011057081A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512710B2 (en) | 2002-11-22 | 2013-08-20 | Ansun Biopharma, Inc. | Class of therapeutic protein based molecules |
| WO2011057081A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
| CN109529026A (zh) * | 2012-02-17 | 2019-03-29 | 安迅生物制药公司 | 用于治疗流感和副流感患者的方法、化合物和组合物 |
| JP2015527310A (ja) | 2012-06-28 | 2015-09-17 | アンサン バイオファーマ, インコーポレイテッドAnsun Biopharma, Inc. | 下気道および中枢気道への送達用微粒子製剤ならびに製造方法 |
| EP2877204A2 (en) * | 2012-06-28 | 2015-06-03 | Ansun Biopharma, Inc. | Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture |
| FR3022256B1 (fr) * | 2014-06-17 | 2018-03-09 | Adisseo France S.A.S. | Nouvelles souches d’arthrobacter gandavensis |
| JP7187024B2 (ja) | 2016-07-01 | 2022-12-12 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 標的化された細胞表面編集のための複合体 |
| CN108926707B (zh) * | 2017-05-26 | 2021-12-03 | 中国医学科学院病原生物学研究所 | Pf4的抗rsv应用 |
| EP3735458A4 (en) | 2018-01-03 | 2022-04-27 | Palleon Pharmaceuticals Inc. | RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS AND METHODS OF USE THEREOF |
| CN109288114A (zh) * | 2018-10-08 | 2019-02-01 | 厦门艾赛生物科技有限公司 | 一种唾液酸及其衍生物的应用和唾液酸电子烟液 |
| US20220356457A1 (en) * | 2019-07-03 | 2022-11-10 | Palleon Pharmaceuticals Inc. | Recombinant human sialidases, sialidase fusion proteins, and methods of using the same |
| AU2021247584B2 (en) * | 2020-04-01 | 2023-11-02 | Lifescience As | Sialic acid compositions for use in inhibiting and treating coronavirus infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7019A (en) * | 1850-01-15 | Improvement in obstetrical supporters | ||
| US8501911B2 (en) * | 1999-02-24 | 2013-08-06 | Biomarck Pharmaceuticals, Ltd | Methods of reducing inflammation and mucus hypersecretion |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| CA2932997C (en) * | 2006-01-24 | 2019-07-30 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| JP2010534563A (ja) * | 2007-07-24 | 2010-11-11 | ネクスバイオ，インク． | マイクロ粒子の作製のための技術 |
| EP2237788A4 (en) * | 2007-12-27 | 2013-06-05 | Aires Pharmaceuticals Inc | COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF |
| WO2011057081A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
-
2010
- 2010-11-05 WO PCT/US2010/055636 patent/WO2011057081A1/en not_active Ceased
- 2010-11-05 JP JP2012538031A patent/JP2013510169A/ja active Pending
- 2010-11-05 AU AU2010315024A patent/AU2010315024B2/en not_active Ceased
- 2010-11-05 CA CA2780193A patent/CA2780193A1/en not_active Abandoned
- 2010-11-05 EP EP10829154.3A patent/EP2496251A4/en not_active Withdrawn
- 2010-11-05 US US12/940,742 patent/US8398971B2/en active Active
- 2010-11-05 CN CN2010800606702A patent/CN102711807A/zh active Pending
-
2012
- 2012-05-03 IL IL219579A patent/IL219579B/en active IP Right Grant
-
2013
- 2013-02-15 US US13/769,095 patent/US20130156703A1/en not_active Abandoned
-
2014
- 2014-09-17 US US14/489,428 patent/US20150017150A1/en not_active Abandoned
-
2016
- 2016-04-22 US US15/136,751 patent/US20160228518A1/en not_active Abandoned
-
2018
- 2018-01-08 US US15/865,217 patent/US20180140683A1/en not_active Abandoned
-
2020
- 2020-06-04 US US16/893,265 patent/US20200297822A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013510169A5 (cg-RX-API-DMAC7.html) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| JP2009537143A5 (cg-RX-API-DMAC7.html) | ||
| WO2010062688A3 (en) | Dosage form for insertion into the mouth | |
| WO2012007839A3 (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| JP2011528895A5 (cg-RX-API-DMAC7.html) | ||
| JP2010202664A5 (cg-RX-API-DMAC7.html) | ||
| WO2010139808A3 (en) | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections | |
| MX2012001882A (es) | Anticuerpos contra el virus sincitial respiratorio (rsv) humano y metodos de uso. | |
| JP2012500090A5 (cg-RX-API-DMAC7.html) | ||
| WO2007092563A3 (en) | Gene therapy for niemann-pick disease type a | |
| JP2009517473A5 (cg-RX-API-DMAC7.html) | ||
| JP2014503593A5 (cg-RX-API-DMAC7.html) | ||
| JP2011528897A5 (cg-RX-API-DMAC7.html) | ||
| JP2013526392A5 (cg-RX-API-DMAC7.html) | ||
| WO2008063511A3 (en) | Methods for treating pompe disease | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| JP2011225596A5 (cg-RX-API-DMAC7.html) | ||
| WO2008064299A3 (en) | Methods of reducing porcine circovirus-associated disease outbreaks | |
| WO2008135038A3 (de) | Diagnose und risikostratifizierung mittels nt-proet-1 | |
| MY153408A (en) | Novel methods | |
| JP2013503110A5 (cg-RX-API-DMAC7.html) | ||
| WO2010068754A3 (en) | Methods and compositions for delivery of medicaments to the lungs | |
| JP2014513722A5 (cg-RX-API-DMAC7.html) | ||
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei |